Drug intelligence / Profile preview

Ascor L 500

Development stage
Phase 1
Lead developer
McGuff Pharmaceuticals
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ascor L 500 is a high‑concentration parenteral formulation of ascorbic acid (vitamin C) at 500 mg/mL, supplied as a sterile solution for injection. It is used to treat or prevent vitamin C deficiency, including scurvy, in situations where parenteral therapy is required, such as when oral administration is not possible, insufficient, or contraindicated. Pharmacologically, ascorbic acid functions as a water‑soluble antioxidant and an essential cofactor for multiple enzymatic reactions, notably in collagen synthesis, carnitine biosynthesis, and catecholamine production, and it facilitates non‑heme iron absorption and reduction. Intravenous or intramuscular administration rapidly restores plasma and tissue vitamin C levels, helping reverse the hematologic, dermatologic, and musculoskeletal manifestations of severe deficiency. At high doses, parenteral ascorbic acid can increase urinary oxalate excretion and acidify urine, which has implications for nephrolithiasis risk and drug–drug interactions, but its core mechanism of action remains nutritional replacement and antioxidant support.

Brand names
Ascor L 500

Beyond the preview

Go deeper on Ascor L 500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascor L 500.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call